Details for Patent: 8,216,180
✉ Email this page to a colleague
Which drugs does patent 8,216,180 protect, and when does it expire?
Patent 8,216,180 protects BYDUREON PEN and is included in one NDA.
Protection for BYDUREON PEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eight patent family members in seven countries.
Summary for Patent: 8,216,180
| Title: | Administering apparatus with functional drive element |
| Abstract: | An apparatus for administering a fluid product, including a housing, a product member for accommodating the fluid product and/or a reservoir for the fluid product, which product member can be moved relative to the housing from a start position to an inserted position along a longitudinal axis of the housing, a drive member in the housing and movable relative to the product member for emptying the fluid product from the product member and/or the reservoir, wherein the drive member has at least one holding element which holds the drive member in the start position of the product member and wherein, by the movement of the product member, the holding element is moved from the holding position to a released position in which the drive member is movable relative to the housing. |
| Inventor(s): | Tschirren; Markus (Kirchberg, CH), Moser; Ulrich (Heimiswil, CH), Hirschel; Juerg (Aarau, CH), Baumert; Jan (Bern, CH), Hattler; Eric (Solothurn, CH) |
| Assignee: | TecPharma Licensing AG (Burgdorf, CH) |
| Application Number: | 12/572,759 |
|
Patent Claim Types: see list of patent claims | Device; |
Drugs Protected by US Patent 8,216,180
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | BYDUREON PEN | exenatide synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200-002 | Feb 28, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,216,180
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2007 016 810 | Apr 5, 2007 |
International Family Members for US Patent 8,216,180
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | E516834 | ⤷ Try a Trial | |||
| China | 101678173 | ⤷ Try a Trial | |||
| Denmark | 2144649 | ⤷ Try a Trial | |||
| European Patent Office | 2144649 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
